Lonza Expands Service Offering for Spray-Dried Biologics for Pulmonary Delivery
Lonza’s new offering provides manufacturing of spray-dried protein formulations, nucleotide-based drugs, and peptides.
Lonza’s new offering provides manufacturing of spray-dried protein formulations, nucleotide-based drugs, and peptides.
Researchers discovered in mice that conditions such as diabetes diagnosed in people with spinal cord injuries, can be linked to abnormal post-injury neuronal activity.
The mini colons replicate both the physical structure and cellular diversity in the colon in both healthy and diseased states.
Regeneron Pharmaceuticals will use Mammoth Biosciences’ CRISPR-based ultracompact gene editing platform to develop in vivo therapies for tissues and cell types beyond the liver.
Matings between two species are often evolutionary dead ends. This one birthed a new species
SCG says it has developed in-house cGMP manufacturing capabilities to supply high-quality cell therapy products to patients.
Two distinguished neuroscientists distill general principles from more than a century of scientific study, “reverse engineering” the brain to understand …
My name is Ricardo Lopes, and I’m from Portugal. Thank you for visiting my podcast. Over the past few years, I have conducted and released…
Synthesia’s new technology is impressive but raises big questions about a world where we increasingly can’t tell what’s real.
Synthesia’s new technology is impressive but raises big questions about a world where we increasingly can’t tell what’s real.
A new study shows that increased levels of a protein named TP53INP2 in muscle correlate with greater muscular strength and healthier aging in humans.